Assignee
KORRO BIO INC
US·6 granted patents·22 pending applications·14 citations·filing 2020–2025
Top patents by PatentIndex Score
28 records- 0195US11479575B2RNA-editing oligonucleotides and uses thereofKORRO BIO INC·Filed 2020·Granted Oct 25, 2022·5 cites·17 claims
- 0294US11453878B2RNA-editing oligonucleotides and uses thereofKORRO BIO INC·Filed 2020·Granted Sep 27, 2022·5 cites·18 claims
- 0393US12031131B2RNA-editing oligonucleotides and uses thereofKORRO BIO INC·Filed 2023·Granted Jul 9, 2024·1 cites·27 claims
- 0492US12448620B2RNA-editing oligonucleotides and uses thereofKORRO BIO INC·Filed 2022·Granted Oct 21, 2025·1 cites·20 claims
- 0592US12173285B2RNA-editing oligonucleotides and uses thereofKORRO BIO INC·Filed 2023·Granted Dec 24, 2024·1 cites·28 claims
- 0692US12152050B2RNA-editing oligonucleotides and uses thereofKORRO BIO INC·Filed 2022·Granted Nov 26, 2024·1 cites·17 claims
- 0785US2025382610A1Rna-editing oligonucleotides and uses thereofKORRO BIO INC·Filed 2025·Application pending·0 cites
- 0883US2025215038A1Rna-editing oligonucleotides and uses thereofKORRO BIO INC·Filed 2024·Application pending·0 cites
- 0980US2025066773A1Rna-editing oligonucleotides and uses thereofKORRO BIO INC·Filed 2024·Application pending·0 cites
- 1068US2025034563A1Methods and Compositions for ADAR-Mediated EditingKORRO BIO INC·Filed 2022·Application pending·0 cites
- 1167US2025034564A1Methods and Compositions for ADAR-Mediated EditingKORRO BIO INC·Filed 2022·Application pending·0 cites
- 1266US2025388903A1Methods and Compositions for Adar-Mediated EditingKORRO BIO INC·Filed 2025·Application pending·0 cites
- 1364US2023257752A1Methods and compositions for the adar-mediated editing of argininosuccinate synthetase (ass1)KORRO BIO INC·Filed 2022·Application pending·0 cites
- 1464US2023272376A1Methods and compositions for the adar-mediated editing of methyl-cpg binding protein 2 (mecp2)KORRO BIO INC·Filed 2022·Application pending·0 cites
- 1564US2023295664A1Methods and compositions for the adar-mediated editing of leucine rich repeat kinase 2 (lrrk2)KORRO BIO INC·Filed 2022·Application pending·0 cites
- 1664US2023295614A1Methods and compositions for the adar-mediated editing of argininosuccinate lyase (asl)KORRO BIO INC·Filed 2022·Application pending·0 cites
- 1764US2023272384A1Methods and compositions for the adar-mediated editing of retinochisin 1 (rs1)KORRO BIO INC·Filed 2022·Application pending·0 cites
- 1864US2023212569A1Methods and compositions for the adar-mediated editing of otoferlin (otof)KORRO BIO INC·Filed 2022·Application pending·0 cites
- 1964US2023272377A1Methods and compositions for the adar-mediated editing of transmembrane channel-like protein 1 (tmc1)KORRO BIO INC·Filed 2022·Application pending·0 cites
- 2064US2023272383A1Methods and compositions for the adar-mediated editing of gap junction protein beta 2 (gjb2)KORRO BIO INC·Filed 2022·Application pending·0 cites
- 2163US2024263177A1Methods and Compositions for Adar-Mediated EditingKORRO BIO INC·Filed 2022·Application pending·0 cites
- 2262US2020385713A1Rna-editing oligonucleotides and uses thereofKORRO BIO INC·Filed 2020·Application pending·0 cites
- 2362US2022307027A1RNA-Editing Enzyme-Recruiting Oligonucleotides and Uses ThereofKORRO BIO INC·Filed 2022·Application pending·0 cites
- 2458US2026071212A1GalNAc conjugated oligonucleotides for RNA editingKORRO BIO INC·Filed 2025·Application pending·0 cites
- 2557US2023174989A1Methods and Compositions for the ADAR-Mediated Editing of ABCA4KORRO BIO INC·Filed 2021·Application pending·0 cites
- 2657US2021380980A1Methods and Compositions for the ADAR-Mediated Editing of SERPINA1KORRO BIO INC·Filed 2021·Application pending·0 cites
- 2757US2025352667A1Methods and compositions for disrupting nrf2-keap1 protein interaction by adar mediated rna editingKORRO BIO INC·Filed 2022·Application pending·0 cites
- 2848US2025340876A1Rna-editing oligonucleotides and uses thereofKORRO BIO INC·Filed 2025·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →